Kawasaki disease (or Kawasaki syndrome) is an acute inflammatory disorder that primarily affects small and medium-sized blood vessels, sometimes causing serious cardiovascular complications such as coronary aneurysms in children. The disease is characterized by a complex of clinical signs, including fever, rash, conjunctivitis, changes in the mucous membranes of the mouth and neck, and enlarged lymph nodes. Kawasaki disease most often occurs in children under 5 years of age, and its etiology remains unclear. It is believed that a combination of genetic predisposition and environmental factors may play a role in the development of this disease.
History of the disease and interesting historical facts
Kawasaki disease was first described by Japanese pediatrician Tomisaku Kawasaki in 1967. He noted unusual cases of acute febrile illness in children that did not correspond to any of the infectious diseases known at that time. Remarkably, the disease was registered in Japan on an epidemic scale, but its spread to other countries became noticeable only decades later. In the 1970s, the disease began to be recorded outside Japan, in many countries in Europe and America. Since then, many studies have been conducted to study the immunological and genetic aspects of the disease. Over the past few decades, the disease has attracted the attention of scientists and doctors, which has contributed to a deeper understanding of it and improved diagnostics and treatment.
Epidemiology
The distribution of Kawasaki disease has marked geographic and racial differences. According to statistics, its incidence is most widespread in Japan, where the incidence rate reaches 15-20 cases per 100,000 children under 5 years of age. In other countries, including the United States and Europe, this figure ranges from 5 to 10 cases per 100,000. The discovery and further study of the disease in other regions showed that the disease is more common in boys than in girls with a ratio of approximately 1.5:1. Thus, statistical data indicate a certain predisposition to the disease both in terms of gender and geographic prevalence.
Genetic predisposition to this disease
Genetic predisposition to Kawasaki disease is currently being actively studied. Studies show that some polymorphisms in genes associated with the immune response may increase the risk of developing the disease. There are associations with genes such as IL-1β, IL-6 and FCGR2A, which are involved in the immune response and inflammatory processes. In addition, a link has been found between X-linked predisposition and some other genetic markers. Despite the existing observations, the mechanism of inheritance of the disease remains complex and, apparently, multifactorial, which makes it difficult to predict.
Risk factors for the development of this disease
Research shows that there are many risk factors that contribute to the development of Kawasaki disease:
- Genetic predisposition;
- Age: most often the disease is detected in children under 5 years of age;
- Gender: boys get sick more often than girls;
- Ethnicity: higher incidence among children of Japanese and Korean descent;
- Infectious factors: some viruses and bacteria can be triggers of the disease;
- Changes in the environment: Climate conditions and pollution can trigger the disease.
Diagnosis of this disease
Diagnosis of Kawasaki disease is based on clinical signs and medical history. The main symptoms include:
- Fever lasting more than 5 days;
- Conjunctivitis (eye inflammation);
- Changes in the mucous membranes of the mouth and throat, including a bright red tongue (strawberry tongue);
- Skin rash;
- Enlarged lymph nodes in the neck;
- Redness and swelling of the extremities.
Laboratory tests include a complete blood count, which may show elevated white blood cell and platelet counts, and a C-reactive protein level, which reflects inflammation. Radiological tests, such as cardiac ultrasound, are needed to evaluate the coronary arteries and detect aneurysms. Differential diagnoses include infectious diseases such as scarlet fever and toxic shock syndrome.
Treatment
Treatment of Kawasaki disease requires a comprehensive approach, since the risk of serious complications, including coronary aneurysms, is high. The main method of treatment is intravenous immunoglobulin, which helps reduce inflammation and prevent cardiovascular complications. Pharmacological treatment includes the use of high-dose aspirin in the acute phase to reduce fever and reduce inflammation, then switch to low doses for antiplatelet therapy. In high-risk cases, the use of steroids (glucocorticoids) is considered for more aggressive control of the inflammatory process. Surgical treatment may be required in case of aneurysm formation, when restoration of coronary artery patency is required. Analysis of clinical data and constant monitoring of the patient's condition play a key role in the prevention of complications.
List of medications used to treat this disease
The main drugs used to treat Kawasaki disease include:
- Intravenous immunoglobulin (IVIG);
- Aspirin (acetylsalicylic acid);
- Glucocorticoids (eg, prednisolone);
- Antibiotics (for concomitant infectious processes);
- Anticoagulants (in some cases to reduce the risk of blood clots).
Disease monitoring
Monitoring of patients with Kawasaki disease includes regular examinations aimed at identifying possible complications, especially those related to the cardiovascular system. Control stages of analysis include:
- Ultrasound of the heart to detect coronary artery aneurysms;
- Regular measurement of blood pressure;
- General clinical tests to monitor inflammatory parameters;
- Electrocardiogram (ECG) to detect changes in rhythm.
The prognosis with adequate treatment is usually good, but complications such as myocardial infarction or other heart problems are possible, which requires constant monitoring of the patient's condition.
Age-related features of the disease
There is a significant difference in the clinical presentation and recognition of Kawasaki disease in children of different ages. In infants, manifestations may be less pronounced, which complicates diagnosis. In adolescents and adults, although extremely rare, cases of the disease may also occur, often with an atypical presentation, which requires a more detailed examination. Older patients may have a more severe course with pronounced cardiovascular complications.
Questions and Answers
- What causes Kawasaki disease? The cause of Kawasaki disease is not fully understood. It is believed that a combination of infectious and genetic factors triggers the development of the disease.
- What are the main symptoms of Kawasaki disease? The main symptoms include high fever, skin rash, conjunctivitis, changes in the mucous membranes and enlarged lymph nodes.
- How is Kawasaki disease diagnosed? Diagnosis is based on clinical symptoms and the results of laboratory and radiological studies, such as cardiac ultrasound.
- Can Kawasaki disease occur in adults? Although Kawasaki disease occurs primarily in children, cases in adolescents and adults have been reported, but they are less common and may have different manifestations.
- What is the likelihood of complications developing after Kawasaki disease? With proper treatment, the likelihood of complications is minimal, but they can occur, especially in the cardiovascular system.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov recommends that parents monitor their children's health and pay attention to any signs of inflammatory diseases. It is important to remember that early diagnosis and treatment can significantly reduce the risk of complications associated with Kawasaki disease. If a child has symptoms such as high fever, red eyes, changes in the tongue, or rashes, it is necessary to immediately consult a doctor. In addition, regular medical examinations with a cardiologist after the disease will help monitor the child's health and avoid subsequent cardiovascular problems.
